OKYO
OKYO Pharma Ltd
1.50$
+9.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | 0.02 | – | – | – | – | – | – | 0.00 | 0.00 | 0.08 | 0.00 | 0.30 | 0.26 | 0.00 | 0.18 | |
| – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | -0.08 | 0.00 | -0.30 | -0.26 | 0.00 | -0.18 | |
| – | – | – | – | – | – | – | – | – | – | – | 0.39 | 0.06 | 0.03 | 0.11 | 0.28 | 0.28 | 0.06 | 0.05 | |
| – | – | – | 0.19 | – | 1.05 | 1.00 | 0.28 | 0.18 | 0.06 | 0.10 | – | – | 0.09 | 0.33 | – | – | – | – | |
| 0.06 | -0.50 | -4.81 | 0.40 | 1.26 | 1.05 | 1.03 | 0.28 | 0.19 | 0.06 | 0.17 | 0.57 | 0.17 | 0.32 | 0.41 | 0.28 | 0.28 | 0.18 | 0.05 | |
| -0.06 | 0.50 | 6.68 | -0.40 | -1.19 | -1.11 | -1.03 | -0.28 | -0.19 | -0.06 | -4.80 | -0.57 | -0.17 | -0.40 | -0.41 | -0.59 | -0.54 | -0.18 | -0.23 | |
| 0.00 | 0.01 | 0.00 | 0.02 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.02 | 0.01 | |
| -0.05 | 0.48 | 2.96 | -0.38 | -1.33 | -1.09 | -3.01 | -0.24 | -0.17 | -0.04 | -4.80 | -0.62 | -0.18 | -0.33 | -0.41 | -0.60 | -0.57 | -0.20 | -0.24 | |
| 0.00 | 0.01 | 1.23 | -0.03 | -0.21 | 0.00 | 0.00 | 1.08 | -0.03 | -0.02 | 0.00 | -0.02 | -0.01 | 0.00 | -0.05 | 0.00 | 0.00 | -0.08 | 0.00 | |
| -0.05 | 0.48 | 2.96 | -0.38 | -1.12 | -1.09 | -3.01 | -1.32 | -0.14 | -0.04 | -4.80 | -0.62 | -0.17 | -0.32 | -0.36 | -0.60 | -0.57 | -0.12 | -0.24 | |
| -0.05 | 0.50 | 7.92 | -0.40 | -1.19 | -1.06 | -1.01 | 0.40 | -0.20 | -0.06 | 4.44 | -0.57 | -0.17 | -0.40 | -0.41 | -0.59 | -0.54 | -0.18 | -0.23 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.